Editorial Board

Amal Kaddoumi
Associate Editor
Auburn University
Auburn, United States
Term Expiration:
12/31/2019
Areas of Interest:
Blood-brain barrier; Alzheimer's disease, amyloid-beta, vascular risk factors for AD and inflammatory-CAA, P-glycoprotein and clearance of amyloid beta; lrp1
Naoki Kasahata, M.D.
Associate Editor
Tokyo Metropolitan Ohtsuka Hospital
Tokyo, Japan
Term Expiration:
12/31/2018
Areas of Interest:
neuropathology, Neurology
Nagaendran Kandiah, MBBS, FRCP (Edin)
Associate Editor
National Neuroscience Institute, Singapore; DUKE-NUS Singapore
Singapore
Term Expiration:
12/31/2020
Areas of Interest:
Cerebrovascular disease and vascular cognitive impairment, mild cognitive impairment, Alzheimer's disease, Parkinson's disease dementia
Rakez Kayed, PhD
Associate Editor
University of Texas Medical Branch
Galveston, United States
Term Expiration:
12/31/2022
Areas of Interest:
Alzheimer's disease, amyloid toxicity, biomarkers, immunotherapy
Ramesh Kandimalla, MSc PhD
Associate Editor
Texas Tech University Health Science Center
Lubbock, United States
Term Expiration:
12/31/2018
Areas of Interest:
Alzheimer and Parkinson Diseases; Mitochondrial Targeted Therapeutics in Alzheimer's disease, Alzheimer's disease mice models, APP trafficking, phospho-tau
Patrick Kehoe, PhD
Associate Editor
University of Bristol
United Kingdom
Term Expiration:
12/31/2024
Areas of Interest:
Alzheimer's disease, amyloid, amyloid-beta degrading enzymes, angiotensin converting enzyme
André Karch, MD MSc
Associate Editor
Helmholtz Centre for Infection Research
Braunschweig, Germany
Term Expiration:
12/31/2020
Areas of Interest:
epidemiology, biostatistics, prion diseases, neurodegeneration
Greg Kennedy, BSc. (Hons)
Associate Editor
Center for Human Psychopharmacology; Swinburne University
Australia
Term Expiration:
12/31/2019
Areas of Interest:
cognitive aging, exercise, Alzheimer disease, vascular and cognitive health

Pages